A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour — Stella

Home/Advanced Malignant Tumour/

View on ClinicalTrials.gov

Recruiting

Back to Advanced Malignant Tumour trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality

Key details

Phase

Early testing

Sponsor

Shandong Suncadia Medicine Co., Ltd.

Enrollment target

~233 participants

Started

June 2024

Primary completion

June 2026

Age range

18 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.